Pfizer Announces Agreement with Puma Biotechnology and Lyrica Success

Pfizer have announced an agreement with Puma Biotechnology for the development and commercialization of neratinib, an investigational oral, multi-targeted inhibitor of the ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4) kinases.  The drug, which shows promise as a treatment for breast cancer, is being studied in the neoadjuvant, adjuvant and advanced settings in HER2/ErbB2 positive breast

Continue Reading

PFIZER JOB FAIR 18th May Sandwich

Clinical Professionals are attending the JOB FAIR OPEN DAY at Pfizer on the 18th May 2011. Pfizer, Global Research & Development Ramsgate Road Sandwich Kent CT13 9NJ We are attending the Job Fair Open Day on Wednesday 18th May 2011 and cordially invite you to participate.  The opening hours will be from 10.30am to 3pm.  We hope to

Continue Reading